TY  - GEN
AU  - Bailey, T S
AU  - Takács, R
AU  - Tinahones, F J
AU  - Rao, P V
AU  - Tsoukas, G M
AU  - Thomsen, A B
AU  - Kaltoft, M S
AU  - Maislos, M
PY  - 2016
DO  - 10.1111/dom.12736
UR  - http://hdl.handle.net/20.500.12105/17155
AB  - To confirm superiority on glycaemic control by switching from sitagliptin to liraglutide 1.8 mg/d versus continued sitagliptin. A randomized, multicentre, double-blind, double-dummy, active-controlled trial across 86 office- or hospital-based sites in...
LA  - eng
KW  - GLP-1 receptor agonist
KW  - liraglutide
KW  - sitagliptin
KW  - type 2 diabetes
KW  - Adult
KW  - Aged
TI  - Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trial.
TY  - research article
ER  -